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ABSTRACT
Objective: The purpose of the study was to evaluate the antitumor and antioxidant status of ethanolic extract of Cyperus kyllingia Endl. on Ehrlich 
ascites carcinoma (EAC)-treated mice.
Methods: The determination of in vivo antitumor activity was performed using EAC cells inoculated mice groups (n=12). The groups were treated for 
9 consecutive days with ethanolic extract of C. kyllingia (EECK) at the doses of 20 and 40 mg/kg b.w., respectively. After 24 h of the last dose, half of the 
mice were sacrificed and the rest were kept alive for assessment of increase in life span. The antitumor potential of EECK was assessed by evaluating 
tumor volume, viable and non-viable tumor cell count, tumor weight, hematological parameters, and biochemical estimations. Furthermore, 
antioxidant parameters were assayed by estimating liver tissue enzymes.
Results: EECK showed direct cytotoxicity on EAC cell line in a dose-dependent manner. EECK exhibited significant (p<0.05) decrease in the tumor 
volume, viable cell count, tumor weight, and elevated the life span of EAC tumor-bearing mice. The hematological profile, biochemical estimations, and 
tissue antioxidant assay were reverted to normal level in EECK-treated mice.
Conclusion: Experimental results revealed that EECK possesses potent antitumor and antioxidant properties. Further, research is going on to find out 
the active principle(s) of EECK for better understanding of mechanism of its antitumor and antioxidant activity.
Keywords: Cyperus kyllingia Endl, Ehrlich ascites carcinoma, Antioxidant, Antitumor, Superoxide dismutase, glutathione.
INTRODUCTION
Cancer is one of the most life-threatening diseases in which a group 
of abnormal cells grows uncontrollably by disregarding the normal 
rules of cell division. Cancer is characterized by uncontrolled growth, 
invasion (intrusion on and destruction of adjacent tissues), and 
metastasis (spread to other locations in the body through lymph 
or blood). It is one of the leading causes of the death worldwide. It 
is estimated that 12.5% of the population dies due to cancer [1]. 
Nowadays, chemotherapy is the most effective treatment for cancer, but 
existing chemotherapeutic agents adversely affect our host cell also, 
especially bone marrow, epithelial tissues, gonads, and the reticula-
endothelial system [2]. Natural products have been the mainstay in 
cancer chemotherapy for the past 30 years. Over 60% of the clinically 
used anticancer drugs are of natural origin and most of them are 
derived from plants [3]. Phytochemicals have minimal toxicity on host 
cell compare to chemotherapeutic agent. Therefore, researches are still 
going on medicinal plants in search of new effective anti-carcinogenic 
agent which can reverse progression of cancer.
Cyperus kyllingia Endl. (Cyperaceae) is a perennial herb with creeping 
underground stem commonly found in tropical regions of the world. 
According to ethnomedical investigation, this plant was found to 
have numerous biological activities such as antidiarrheal, diuretic, 
stomachic, anthelmintic, and expectorant activities, and it is also 
used in fever, hepatopathy, splenopathy, diabetes, and tumors [4]. 
Previously, phytochemical analysis was performed and terpenes such 
as α-cyperone, β-selinene, and α-humulene were found in underground 
part of this plant [5]. The present study was carried out to evaluate the 
anticancer effect of root extract of C. kyllingia Endl. against Ehrlich’s 
ascites carcinoma (EAC) in Swiss albino mice. There is no scientific 
report available on biological effect of root extract from C. kyllingia Endl. 
Therefore, this effort has been made to investigate the antiproliferative 
effect of C. kyllingia Endl.
METHODS
Chemicals
5-fluorouracil from Sigma (St. Louis, MO); trichloroacetic acid from 
Merck (Mumbai, India); thiobarbituric acid, nitroblue tetrazolium 
chloride from Loba Chemie (Mumbai, India); 5,5′-dithiobis-2-
nitrobenzoic acid, phenazonium methosulfate, nicotinamide adenine 
dinucleotide, and reduced glutathione (GSH) from SISCO (Mumbai, 
India). All the other reagents used were of analytical reagent grade 
obtained commercially.
Plant collection and extraction
The plant was collected from the Sonamukhi forest range of Ichharia 
village, Bankura, West Bengal, India. Moreover, the specimen was 
authenticated by B.S.I.(CNH/71/2011/Tech.II/), Shibpur, Howrah, West 
Bengal, India. In brief, the roots were carefully washed under running tap 
water followed by sterile distilled water and dried at room temperature 
for 5 days. Then, roots were pulverized to a fine powder and stored 
in air-tight bottles. The root powder was extracted with ethanolic by 
Soxhlet extraction apparatus. The extract was then kept in distillation 
for solvent evaporation and remaining solvent was completely removed 
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under reduced pressure in a rotary vacuum evaporator (Buchi R-210). 
The concentrated extract was stored in vacuum desiccators.
Animals
Male Swiss albino mice, an average body weight 20–22 g, were taken 
for this experiment. The mice were obtained from the animal house, 
B. N. Ghosh and Co. Kolkata, India, and were grouped and housed 
in polyacrylic cages (38 cm×23 cm×10 cm) with not more than six 
animals per cage. Animals were maintained under standard laboratory 
conditions (temperature 25 ± 2 °C and dark/light cycle 14/10 h). They 
were allowed free access to standard dry pellet diet (Hindustan Lever, 
Kolkata, India) and water ad libitum. The mice were acclimatized 
to laboratory conditions for 7 days before commencement of the 
experiment. All procedures described were reviewed and approved by 
the University Animal Ethical Committee.
Transplantation of tumor cell
EAC cells were obtained from Chittaranjan National Cancer Institute, 
Kolkata, India. The EAC cells were maintained in vivo in Swiss albino 
mice by intraperitoneal transplantation of 2×106 cells per mouse after 
every 10 days. Ascetic fluid was drawn out from EAC cell-bearing mouse 
at the log phase (days 7–8 of tumor bearing) of the tumor cells. Each 
animal injected intraperitonially with 0.1 ml of tumor cell suspension 
containing 2×106 tumor cell [6].
Determination of acute toxicity
As per OECD guideline 425, the acute oral toxicity of EECK in Swiss 
albino mice was performed as per previously described method 
Gangopadhyay et al., 2017 [7,8].
Treatment schedule
A total of 60 Swiss albino mice were divided into five groups (n=12) and 
given food and water ad libitum. All the animals in each group, except 
Group-I (normal control), received EAC cells (2×106cells/mouse i. p.). 
This was taken as day “0.” Group-I served as normal saline (5 ml/kg i. 
p.) and Group-II served as EAC control. 24 h after EAC transplantation, 
Group-III and IV received ethanolic extract of C. kyllingia (EECK) root 
at a dose of 20 and 40 mg/kg i. p. for 9 consecutive days, respectively. 
Group-V received reference drug 5-FU (20 mg/kg i. p.) for 9 consecutive 
days [9]. 24 h of last dose, six animals of each group were sacrificed 
by cervical dislocation to measure antitumor, hematological, and 
biochemical parameters (livers) and rest of the animals were kept with 
food and water ad libitum to check percentage increase life span of 
the tumor host. The anticancer activity of EECK was measured in EAC 
animals with respect to the following parameters.
Determination of biochemical parameters
Serum biochemical parameter such as total proteins, serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate 
transaminase (SGPT), serum alkaline phosphatase (SALP), and serum 
bilirubin was done using commercially available kits manufactured by 
the Span Diagnostics Ltd., Surat, India.
Determination of tumor volume, packed cell volume, and tumor 
weight
The mice were dissected and the ascites fluid was collected from the 
peritoneal cavity. Tumor volume, packed cell volume, and tumor 
weight were measured according to the previously described standard 
methods in our laboratory [10].
Determination of viable and non-viable tumor cell count
The ascites fluid was taken in a white blood cell (WBC) pipette and 
diluted 100 times. Then, a drop of the diluted suspension was paled on 
the Neubauer counting chamber, and the cells were then stained with 
Trypan blue (0.4% in normal saline) dye. The cells that did not take up 
the dye were viable and those took the stain were non-viable. These 
viable and non-viable cells were counted [11].
(numberof cells×dilutionfactor)Cellcount=
(area×thicknessof liquidflim)
Determination of percentage increase life span (% ILS)
The effect of EECK on percentage increased in life span was calculated 
on the basis of the mortality rates of the experimental mice [10].
ILS % = (
Mean survival time of treated group
Mean survival time of untreated group
1)  100− ×
Mean survival time = 
First death+last death
2
Determination of hematological parameters
At the end of the experimental period, the next day after an overnight 
fasting blood was collected from freely flowing tail vein and used for 
estimation of hemoglobin (Hb) content, red blood cell (RBC) count, 
WBC count, and lymphocyte count by standard procedures [2].
Determination of tissue antioxidant parameters
Blood was collected from mice by cardiac puncture and was kept for 
15 min for clotting and then centrifuged at 5000 rpm for 10 min. The 
supernatants (serum) were collected and total protein, bilirubin, ALT, 
ASt, and ALP were determined using the diagnostic reagent kit (Span 
Diagnostics Ltd., Surat, India), using the autoanalyzer instrument 
(SELECTRA PRO XS, Merck Limited, Germany).
Statistical analysis
Statistical analysis was performed using GraphPad Prism (version 5.0, 
GraphPad Software Inc., San Diego, CA) software. The experimental 
results were expressed as mean ± standard error of mean. Statistical 
significance was analyzed by one-way ANOVA followed by Dunnett’s post 
hoc test of significance. p<0.05 was considered as statistically significant.
RESULTS AND DISCUSSION
Determination of acute toxicity
The LD50 of the C. kyllingia ethanolic root extract was found to be 
251.3014 mg/kg body weight for i.p. According to OECD guidelines, it 
is considered as a LD50 cutoff value. Dose selected for pharmacological 
studies by fixed dose methods is mentioned below. Ethanolic extracts of 
C. kyllingia roots used for anticancer study were 20 and 40 mg/kg body 
weight which were much lower than the LD50.
Determination of direct tumor-related parameters
Antitumor activity of EECK against EAC tumor-bearing mice was 
assessed by the parameters such as tumor volume, packed cell volume, 
cell count (viable and non-viable), mean survival time, and percentage 
increase of life span. The results are shown in Table 1. Tumor volume 
and packed cell volume were significantly decreased in EECK-treated 
group in compare with normal control group. Viable cell count was 
significantly low in EECK-treated group at the dose of 20 mg/kg and 
40 mg/kg and non-viable cell count was comparatively increased in 
EECK-treated group than the EAC control group. Furthermore, mean 
survival time and percentage increase of life span were increased on 
EECK-treated group in a dose-dependent manner. From these results, 
it can be concluded that EECK extract has antitumor activity on EAC-
induced mice in a dose-dependent manner.
Hematological parameters
RBC level was decreased in EAC control group and WBC level was 
increased in EAC control group as compare with normal group according 
to Table 2. It was seen that RBC and Hb content was increased and WBC 
count was significantly reduced in EECK-treated group as compared 
with EAC control group.
Biochemical parameters
Biochemical parameters such as TP, SGOT, SGPT, and SALP levels 
were discussed in Table 3. SGOT, SGPT, and SALP levels are lower in 
normal group compare to EAC control group and TP level is higher 
in normal group than EAC control group. It was estimated that SGOT 
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and SGPT levels were significantly decreased in EECK-treated group 
(20 mg/kg and 40 mg/kg) in a dose-dependent manner. SALP level 
was decreased in EECK-treated group compare to EAC control group, 
and it was significant in 40 mg/kg. TP level was increased in EECK-
treated group in a dose-dependent manner as compared with EAC 
control group.
DISCUSSION
The present investigation was carried out to evaluate the 
antiproliferative property of ethanolic extract of indigenous plant of 
West Bengal region, i.e., C. kyllingia Endl. in EAC tumor-bearing mice. 
The EECK-treated animals at the doses 20 and 40 mg/kg significantly 
inhibited the tumor volume, packed cell volume, viable tumor cell 
count, and back the hematological parameters toward normal levels. In 
EAC tumor-bearing mice, rapid increase in ascites tumor volume was 
observed. Nutritional source for tumor cells is ascites fluid, and a rapid 
increase in ascites fluid with tumor growth would be a means to meet 
the nutritional requirement of tumor cells [3]. Treatment with EECK 
decreased the tumor volume, viable tumor cell count, and increased the 
life span of the tumor-bearing mice. The main criteria for any anticancer 
drug are the prolongation of the life span of animal [10]. In the present 
study, EECK increases the life span of EAC-bearing mice.
Usually, in cancer chemotherapy, the major problems that are being 
encountered are hematological problems. To restore the hematological 
parameter toward normal level by treatment with EECK clearly 
indicates that the extract having protective action on hemopoietic 
system also.
The lack of balance between the reactive oxygen metabolites and 
the antioxidant defense systems leads to “oxidative stress” which 
deregulates various cellular functions causing pathological conditions. 
Reactive oxygen species formed in cancer tissues result in lipid 
peroxidation and subsequent increase in MDA and other TBARS 
levels. MDA, the end product of lipid peroxidation, a biomarker of 
oxidative stress, was reported to be higher in cancer tissues than in 
the non-diseased organ [12]. The present study showed that there is 
an increased level of TBARS in the EAC-bearing liver tissues but after 
treatment with EECK inhibited hepatic lipid peroxidation as revealed 
by reduction of MDA levels toward normal levels (Fig. 1). This indicated 
the reduction in free radical generation by EECK in tumor-bearing mice.
Table 1: Determination of direct tumor-related parameters
Groups Tumor Volume (ml) Packed cell volume (ml) Cell count (×107/ml) MST (day) ILS%
Viable Non-viable
EAC control 2.40±0.05 2.02±0.03 7.70±0.22 0.66±0.06 19 00
EAC+20 mg/kg 1.98±0.04* 1.62±0.02* 6.40±0.22* 3.94±0.09* 23 21.05
EAC+40 mg/kg 1.78±0.04* 1.40±0.03* 5.33±0.23* 4.46±0.23* 26 36.84
EAC+5-FU (20 mg/kg) 0.70±0.04* 0.28±0.03* 2.71±0.15* 5.33±0.23* 38 100
Shows the effect of EECK on various parameters such as tumor volume, packed cell volume, percentage of viable and non-viable cells, mean survival time, and the 
increase in life span. Values are represented as mean±SEM. *p<0.05 when EAC control compared with treated groups. EECK: Ethanolic extract of Cyperus kyllingia,  
EAC: Ehrlich ascites carcinoma, SEM: Standard error of the mean
Table 2: Hematological parameters
Parameters Normal EAC 
control
20 mg/kg EECK 40 mg/kg EECK 20 mg/kg 5-FU
RBC (cell×106/mm3) 5.48±0.10 2.45±0.17*a 3.15±0.14 4.15±0.17#b 5.35±0.25#b
WBC (cell×106/mm3) 4.43±0.23 7.5±0.28*a 6.4±0.23 5.33±0.24#b 5.09±0.10#b
Hb (g/dl) 11.79±0.23 4.47±0.29*a 5.44±0.28#b 6.73±0.27#b 8.44±0.29#b
Effect of different concentration of the extracts on hematological parameters. Values are represented as mean±SEM. *ap<0.05 when EAC control compared to normal, 
#bp<0.05, EAC control compared with treated groups. EECK: Ethanolic extract of Cyperus kyllingia, EAC: Ehrlich ascites carcinoma, SEM: Standard error of the mean
Table 3: Biochemical parameters
Parameters Normal EAC control 20 mg/kg 40 mg/kg 20 mg/kg 5-FU
TP (g/dl) 8.61±0.31 4.25±0.24 5.02±0.03 6.7±0.37 8.38±0.28
SGOT (IU/L) 77.33±1.45 164.3±5.60# 156.7±4.41* 98.33±4.41* 85.67±2.96*
SGPT (IU/L) 38.00±4.93 95±8.66# 86.67±8.81* 71.67±6* 45±7.63*
SALP (KA/U) 73.33±6.09 155±12.58# 131.7±6.09 110±5.77* 81.67±17.40*
Effects of different concentrations of the extract on serum parameters. Values are represented as mean±SEM. #p<0.05 when EAC control compared to normal, *p<0.05 
when EAC control compared with treated groups. SGOT: Serum glutamate oxaloacetate transaminase, SGPT: Serum glutamate pyruvate transaminase, SALP: Serum 
alkaline phosphatase, EAC: Ehrlich ascites carcinoma, SEM: Standard error of the mean
Fig. 1: Tissue antioxidant parameter. Effects of different 
concentrations of ethanolic extract of Cyperus kyllingia on lipid 
peroxide, superoxide dismutase, and glutathione. The values 
are represented as mean ± standard error of the mean. a*p<0.05 
when Ehrlich ascites carcinoma (EAC) control compared to 
normal liver and kidney, b#p <0.05 when treated groups compared 
to EAC liver and EAC kidney
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GSH, a potent inhibitor of neoplastic proliferation process, plays 
a crucial role as an endogenous antioxidant system. It was found 
particularly in high concentration in liver and is known to have a key 
function in the protective process [10]. The level of reduced GSH was 
decreased in cancer-bearing mice which may be due to its utilization 
by the excessive amount of free radicals generated in the disease state. 
Treatment with EECK was found to increase the GSH content in the liver 
and kidney as compared to the tumor control group (Fig. 1).
Superoxide dismutase (SOD), CAT, and GSH peroxides are involved in the 
clearance of superoxide and hydrogen peroxide (H2O2). SOD catalyzes 
the diminution of superoxide into H2O2, which has to be eliminated 
by GSH peroxidase and/or catalase. Further, it has been reported that 
a decrease in SOD activity in EAC-bearing mice may be due to loss of 
Mn2+ containing SOD activity or due to neutralization of superoxide in 
EAC cells and the loss of mitochondria, leading to a decrease in total 
SOD activity in the liver [13]. The present study showed that there is a 
decreased level of SOD in the EAC-bearing tissues, but after treatment 
with EECK, it restored the SOD level toward normal (Fig. 1).
CONCLUSION
Cancer results from a series of molecular events that fundamentally 
alter the normal properties of cells. In cancer cells, the normal control 
systems that prevent cell overgrowth and the invasion of other tissues 
are disabled [14]. Current cancer chemotherapy can damage or kill 
the rapid dividing healthy cells and causes serious side effects such as 
neutropenia and anemia. In addition, the cost of chemotherapy drug is 
high. Natural compounds may reduce these problems. Currently, a few 
plant products are being used to treat cancer effectively [15-17].
The ethanolic extract of Cyperus kyllingia root possesses significant 
anticancer activity in vivo and increased the life span of tumor-
bearing mice. The phytochemical study confirmed the presence of 
compounds, namely glycosides, saponins, flavonoids, tannins, and 
phenolic compound, in ethanolic extract of C. kyllingia root which may 
possess these properties. The result of the present investigation is quite 
encouraging, and it explores the potent anticancer activity of ethanolic 
extract of C. kyllingia root probably because of its direct cytotoxic effect 
which is further potentiated by its antioxidant properties. Further, 
investigations are in progress in our laboratory to identify the active 
principles involved in this anticancer activity.
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